AndoA.MoriH.AndoI.HirakiT.HisadaK. (1977). Whole-body retention studies of 169Yb-citrate-estimation of radiation dose to humans from 169Yb-citrate. Radioisotopes (Tokyo)26, 602–605.
2.
AnzaiI.KannoM.TobariH.HigashiT. (1974). Skeletal dose estimation of the patient administered ytterbium-169 citrate for tumor diagnosis. Radioisotopes (Tokyo)23, 59–63.
3.
BaltrukiewiczZ.BurakowskiT.Pogorzelska-LisM. (1975). Distribution and retention of 169YbCl3, 169Yb-EDTA and 169Yb-DTPA injected intravenously in the rat. Acta Physiol. Pol. 26, 205–212.
4.
BeyerG. J.FrankeW. G.HennigK.JohannsenB. A.KhalkinV. A.KretzschmarM.LebedevN. A.MünzeR.NovgorodovA. F.ThiemeK. (1978). Comparative kinetic studies of simultaneously injected 167Tm- and 67Ga-citrate in normal and tumour bearing mice. Int. J. Appl. Radiat. Isot. 29, 673–681.
5.
Von FrankeW. G.KühneA.HenkeE.JohannsenB. A. (1976). Ergebnisse der Tumorszintigraphie mit 169Ytterbiumzitrat, Dt. Gesundh. Wesen 31, 2272–2278.
6.
HisadaK.AndoA. (1973). Radiolanthanides as promising tumor scanning agents. J. Nucl. Med. 14, 615–617.
7.
HigasiT.FujimuraT.NakayamaY.HisadaT.TomuraK.KawaiK.NakamuraK. (1973). On the accumulation of 169Yb-citrate in malignant tumor. Kaku Igaku. 10, 27–35.
8.
ICRP Publication 23. Report of the Task Group on Reference Man. Pergamon Press, Oxford, 1975.
9.
MoskalevYu. I.ZalikinG. A.StepanovV. S. (1972). Distinctions of distribution in the organism of radioactive isotopes of lanthanide elements. In: Biologicheskoye deystviye vneshnikh i vnutrennikh istochnikov radiatsii, pp. 183–190 (eds. MoskalevYu. I.KalistratovaV. S.). Moscow. Translated in Biological effects of radiation from external and internal sources, AEC-tr-7457, pp. 278–287.
10.
TatsunoI.BunkoH.KatoS. (1974). Bone tumor imaging with 169Yb-citrate. Kaku Igaku. 11, 471–478.